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We describe a multistage approach to identify single nucleotide polymorphisms (SNPs)
associated with neuroticism, a personality trait that shares genetic determinants with major
depression and anxiety disorders. Whole genome association with 452 574 SNPs was
performed on DNA pools fromB2000 individuals selected on extremes of neuroticism scores
from a cohort of 88 142 people from southwest England. The most significant SNPs were then
genotyped on independent samples to replicate findings. We were able to replicate association
of one SNP within the PDE4D gene in a second sample collected by our laboratory and in
a family-based test in an independent sample; however, the SNP was not significantly
associated with neuroticism in two other independent samples. We also observed an
enrichment of low P-values in known regions of copy number variations. Simulation indicates
that our study had B80% power to identify neuroticism loci in the genome with odds ratio
(OR) > 2, and B50% power to identify small effects (OR = 1.5). Since we failed to find any loci
accounting for more than 1% of the variance, the heritability of neuroticism probably arises
from many loci each explaining much less than 1%. Our findings argue the need for much
larger samples than anticipated in genetic association studies and that the biological basis of
emotional disorders is extremely complex.
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Introduction
Ever since neuroticism was first proposed as person-
ality trait that reflects a tendency toward states of
negative affect,1 it has been included in nearly every
theory of personality. Its importance as a psycho-
logical construct is further enhanced by its well
documented correlation with common psychiatric
disorders, that is, high levels of neuroticism predict
the onset and subsequent episodes of major depres-
sion2–5 and are associated with symptoms of depres-
sion and anxiety in the general population.6–9 The
correlation between anxiety, major depression and
neuroticism is, in part, due to the presence of shared
genetic factors,10–13 an observation that has spurred
attempts to map the genetic basis of neuroticism.14–16
It is much easier to acquire the large samples
necessary for genetic studies of neuroticism, which
is assessed using a self-administered questionnaire,
than it is to acquire large patient samples that require
diagnostic interviews for accurate assessment of
major depression and anxiety.
Genetic linkage analysis has had mixed success in
mapping susceptibility loci for neuroticism. One
study of extremely discordant and concordant sib-
lings identified five loci that exceeded a 5% genome-
wide significance threshold,14 but a second study,
also using a selected sample, failed to identify any
genome-wide significant signals.15 One explanation
for the difficulties encountered is that the proportion
of genetic variance attributable to an individual locus
is extremely small, so that the linkage studies are
underpowered. A recent survey of some 50 meta-
analyses and 752 individual studies concluded that
the typical effect sizes of individual genetic variants
for complex disease ranged from 1.2 to 1.6.17
Whole genome association provides an alternative
approach to detect small genetic effects. This is still
an expensive option, but costs can be reduced by
pooling equal amounts of DNA from each individual,
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separately for cases and controls, and estimating
allele frequencies from the DNA pools (allelotyping).
Even though allelotyping is replicated several times
to increase accuracy, there is still a 10- to 100-fold
decrease in cost compared to individual genotyping.
DNA pooling can also be applied to quantitative traits
in a method known as selective DNA pooling.18
Selective DNA pooling combines DNA pooling and
selective genotyping, which is the genotyping of
individuals only from the extreme of the distribution,
with the most informative trait values. While DNA
pooling offers a substantial reduction in genotyping
cost, it possesses some disadvantages, primarily in
the loss of information (genotype and haplotype
distributions) and by introducing estimation errors.
Recent studies have shown the feasibility and
accuracy of estimating single-nucleotide polymorph-
ism (SNP) allele frequencies in DNA pools using
microarrays containing thousands of SNPs,19–23 which
makes it possible to perform whole genome associa-
tion studies in a cost-effective way.
We have collected a sample suitable for association
studies of small genetic effects on neuroticism. We
selected B3600 individuals from a very large com-
munity cohort (n = 88 142) from southwest England,
on the basis of the extremity of their neuroticism
scores. Using a genomic control approach we have
previously shown that stratification is unlikely to be a
major confusion in the sample.24–26 Here we describe
a multistage approach to identify SNPs associated
with neuroticism in this as well as in replication
samples. Although our initial sample was pheno-
typed for other personality dimensions, the sample
used in this study was selected for having extreme
neuroticism score and thus it is not suitable for the
study of other dimensions.
Materials and methods
The sample
Individuals were selected from the patient registers of
general practices in four counties in southwest
England, that is, Oxfordshire, Gloucestershire, Som-
erset and Berkshire (as described by Fullerton et al.14
and Martin et al.27). We chose patients in rural
practices, so that the sample is likely to be relatively
genetically homogeneous. A total of more than 88 141
individuals completed the revised Eysenck Person-
ality Questionnaire (EPQ). The neuroticism (N) scale
of the EPQ consists of 23 questions scored on a two-
point scale (0 or 1).28 N scores of the EPQ are
correlated with similar measures on other personality
measures such as the NEO PI-R N scale and the
TPQ.29,30 The total scores were regressed on age and
sex and the residuals were standardized so that each
individual’s score is expressed in s.d. units.
From this population, two independent samples
were selected for genotyping according to the extreme-
ness of EPQ–N scores. The first population, originally
selected for neuroticism linkage mapping, consists of
one member of extremely concordant and discordant
sibling pairs (as described by Fullerton et al.14 and
Martin et al.27), while the second population, collected
for genetic association, consists of singletons (as
described by Willis-Owen et al.24). For the singletons,
we received around 20% replies to our request of DNA
samples. There was no difference in the distribution of
N scores between subjects that replied and the ones
that did not reply. We also received an equivalent rate
of reply from high and low N extreme groups.
We screened a total of 3589 individuals; the first
group of 2054 individuals was used in the whole
genome scan with DNA pools and the second group of
1534 individuals was used as a replication sample.
Out of the 2054 individuals (1038 high N and 1016
low N) that were included in the pools, 1301 were
women and 753 were men. The replication sample
consisted of 932 women and 601 men (831 high N and
702 low N). This study was approved by a research
ethics committee in the UK, and appropriate in-
formed consent was obtained.
DNA pools
DNA samples were collected and extracted from
mouth swabs, quantified four times using the Pico-
Green assay (Molecular Probes, Eugene, OR, USA)
and tested by PCR. The samples were divided into
eight groups according to N score (high and low) and
gender (men and women). Equal amounts of DNA
(150 ng) from each subject were mixed together to
create 48 small pools, which on average were made
from 43 individuals. Eight different pools were then
created once by combining DNA from the small pools
in proportion to the number of individuals in each
pool. The eight pools are as follows: (1) men with high
N score (n = 112), (2) men with low N score (n = 158),
(3) men with very high N score (n = 245), (4) men with
very low N score (n = 238), (5) women with high N
score (n = 320), (6) women with low N score (n = 205),
(7) women with very N high score (n = 340) and (8)
women with very N low score (n = 436) (very high or
low N scores are more than 1.5 s.d. from the mean
score adjusted to age and sex (on average 2 s.d.); high
and low N scores are between 1 and 1.5 s.d. from the
mean score (on average 1.3 s.d.)).
We tested the accuracy of the pools before starting
the experiment with the Affymetrix arrays by indivi-
dually genotyping five SNPs and allelotyping the
pools seven times using the Sequenom platform.
Frequencies were averaged and corrected for unequal
detection of the two alleles based on the ratios in
individual heterozygotes.31 The pools were found to
be very accurate, with an s.d. from the expected
frequency of 0.016 for each of the eight large pools.
The s.d. attributed to the pools (construction error)
without the measurement error is estimated to be
0.012 for each pool and 0.0059 for frequency estimate
for the high and low N groups with four pools in each.
The observed frequencies were highly correlated with
the expected frequencies for the small pools and, as
expected, higher for the eight large pools (small pools:
R2 = 98.8%; large pools: R2 = 99.7%).
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Allelotyping with Affymetrix chips
We used the Affymetrix 100 and 500 K mapping arrays
sets. The arrays and the number of SNPs on each array
are as follows: Nsp array with 255 931 SNPs, Sty with
238 304 SNPs, Hind with 57 244 SNPs and Xba
with 58 960 SNPs. The total number of unique SNPs
with dbSNP rs ID numbers is 577 889 (31 462 SNPs are
present on more than one array). Out of those, 452 574
SNPs have a minor allele frequency above 5%.
According to the manufacturer’s protocol, 250 ng
from each pool was digested with a restriction
enzyme, ligated to an adaptor, amplified, fragmented,
labeled and hybridized to the chip. Washing and
staining was performed using the Fluidics Station 450
and scanned using the GeneChip Scanner 3000 7G.
Each DNA pool was amplified and hybridized five
times to different chips of the same type. The
detection rate (MDR) for the 100 K arrays was above
99% for all arrays. For the early access to 500 K arrays
the detection rate (MDR) was not available. Water,
instead of DNA, was used as a negative control to test
for contamination and the manufacturer’s individual
reference DNA as a positive control to test for assay
performance. Accuracy of genotyping call of the
reference DNA was 99.8%.
Data analysis of DNA pools
An allele frequency estimate was calculated based on
the relative intensities of the two alleles (know as the
relative allele score; RAS) for each SNP and for each
of the eight pools.32 The frequency estimate in each
pool is the average across the five measurements.
Frequency estimates for high and low N were
obtained from the average frequency in the four pools
belonging to each category. An SNP-specific variance
was estimated by calculating the variance of the five
measurements for each DNA pool across the eight
pools (s2pool). The allele frequencies from HapMap
Centre d’Etude du Polymorphisme Humain (CEPH)
trios were used as an estimate for the allele frequen-
cies in the population (P^). We modified the standard
chi-squared statistic to include the error variance
introduced by the DNA pooling procedure. The test
statistic is expressed as:
Z ¼ PH  PLﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
P^ð1 P^Þ 12NH þ 12NL
h i
þ s2pool 1npH þ 1npL
h ir
where PH is the frequency in high N pools and PL in
low N pools, NH is the number of individuals in high
N pools and NL is the number of individuals in low N
pools and npH and npL are the number of measure-
ments for high and low N pools. P-values were
calculated using a chi-squared distribution for all
SNPs with a minor allele frequency above 0.05.
We did not attempt to produce a test statistic
with desirable statistical properties. The log P values
calculated based on this statistic do not correspond
to the expected type I error and were only used to
rank and prioritize the SNPs for individual geno-
typing. The empirical distribution of the pools’ log
P values was assessed using a simulation with a null
effect (see below).
Simulation
To estimate a genome-wide significance threshold,
we generated 1000 panels of 4000 chromosomes by
random sampling with the replacement from the
phased HapMap data (n = 120 from unrelated indivi-
duals in CEU).33 For each panel we calculated the
significance of allele frequency differences between
two groups of 2000 chromosomes for all SNPs with a
minor allele frequency greater than 0.05, included in
the 500 and 100 K Affymetrix arrays. The most
significant value in each panel was recorded.
For each SNP in the DNA pooling simulation the
allele frequency in the HapMap CEPH sample was
used. To simulate the errors introduced by the DNA
pooling procedure we first generated a random
normal deviate from the true HapMap frequency
using the estimated construction error variance.
We then assigned a number of measurements to
each simulated pool with an error based on the
SNP-specific measurement error and assumed a
normal distribution.
To evaluate the power of individual genotyping and
DNA pooling we designated 2556 random SNPs from
the HapMap (whether they were included in the
arrays or not) to be the causal variant with an effect
size, measured in terms of odds ratios (ORs), of 1.2,
1.3, 1.5, 1.7, 2 and 3. All the SNPs in HapMap phase II
with minor allele frequency (MAF) > 0.05, in the
CEPH population,33 had an equal chance (0.1%) of
being the causal variant. Based on the frequency of
the causal SNP, we assigned the allele frequencies to
two groups with a frequency difference that corre-
sponded to the effect sizes. We sampled phased
chromosomes with different probabilities based on
the allele frequencies. We calculated the significance
of the allelic w2 test at the causal SNP and for SNPs in
a 100 kb window surrounding the causal SNP that are
included in the Affymetrix arrays. For the DNA
pooling we introduced two sources of error, that is,
construction error and measurement error, as
described above. Similar to our study design, we
simulated 20 measurements for each of the two
groups for all SNPs in the 100 kb window. We
calculated the significance of each SNP in the same
way used for the real allelotyping data. For
the individual genotyping simulation we recorded
the minimum P-value across all SNPs in the window.
For the DNA pooling we simulated a design where
all SNPs with log P > 4 (the negative logarithm, base
10, of the P-value) were individually genotyped. To
simulate this design, we recorded the minimum
P-value of the individual genotypes across all SNPs
in the window that exceeded a log P of 4 in the DNA
pooling simulation.
Individual genotyping
Individual genotyping was performed using the
Sequenom MassArray platform according to the
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manufacturer’s instructions (SEQUENOM, San Diego,
CA, USA). The DNA samples in the pools were
genotyped using the iPLEX assay with up to 29
SNPs multiplexed together. The replication sample
was genotyped using the homogenous MassEXTEND
(hME) assay. Chips were read using the Bruker
Autoflex Mass Spectrometer system (Bruker-Seque-
nom, San Diego, CA, USA). As a quality control for
the iPLEX assay we genotyped 69 HapMap CEPH
DNA samples with known genotypes. The concor-
dance level between the genotypes was on average
99.4%. Hardy–Weinberg (HW) equilibrium was tested
on all SNPs, but was not used automatically to
exclude SNPs because all samples used are selected
from the extreme of the population and might show
deviation from HW in SNPs associated with the trait.
To check the genotyping quality of SNP rs702543, we
compared 634 genotypes obtained using the HME and
iPLEX assays. The concordance level was 100%.
Haplotypes were analyzed based on a score statistic
using ‘haplo.stats’ package for R.34
Results
Sensitivity and specificity of DNA pooling
The design and interpretation of the DNA pooling
experiment require an assessment of the method’s
likely power, that is, its sensitivity and specificity. If
we were to genotype all 2000 individuals individu-
ally, we would be able to detect an effect explaining 1,
0.5 and 0.1% (ORs of 1.72, 1.47 and 1.19) of the
additive genetic variance with power of 0.94, 0.34 and
0.001, respectively (assuming an alpha of 1.66107
(300 000 independent tests, a complete linkage dis-
equilibrium (LD) between the marker and the causa-
tive SNP and a trait increasing allele frequency of
0.2)). If we test only 20 markers, for example, in a
replication sample, our power is 1, 0.96 and 0.19 for
1, 0.5 and 0.1% effects, respectively.
To investigate the pooling strategy we simulated the
design of the study in which we used eight different
pools, each allelotyped five times (that is, 20
measurements for each group). Using samples of
CEPH individuals genotyped as part of the HapMap
project,33 we established that we could accurately
simulate the pooling experiment (see Supplementary
material for a full description). We first simulated a
situation with a null effect and found that the
genome-wide 5% threshold for individual genotyping
is 1.7107 (log P = 6.77), which is equivalent to a 5%
threshold after applying a Bonferroni correction for
294 071 independent tests. Then, by simulation, we
determined the power to detect an association by
genotyping directly the simulated causal SNP, by
individual genotyping of SNPs on the Affymetrix
arrays (500 and 100 K with MAF > 0.05) and using a
DNA pooling strategy. We designed a random SNP
from the HapMap to be a causal SNP and we looked at
SNPs in the array within a 100 kb window. By
simulating an SNP from the HapMap as a causal
SNP we include in our simulation the effect of the
coverage of the arrays (the LD between the SNPs on
the array and SNPs in the genome, represented by
HapMap data) and the possibility that more than one
SNP on the array is in LD with the causal SNP.
We looked at two study designs. In the first design,
we assessed our ability to detect an SNP that exceeds
the 5% genome-wide threshold (log P = 6.77). In the
second design, we assessed what would happen
when we test in a second sample all SNPs that exceed
a log P of 3 in the analysis of the first sample. We
calculated the power using different effect sizes of OR
between 1.2 and 3 (Table 1). For small effect sizes,
that is, ORs of 1.2, 1.3 and 1.5, the power to exceed
the 5% genome-wide threshold using the DNA
pooling strategy is 0, 3 and 31%, respectively. This
is around 75% of the power achieved by individual
genotyping, but incurs only 2% of the cost (404
arrays relative to 2000 4). For the study design that
includes testing all log P > 3 SNPs in a second sample,
power is the probability of inclusion in the list for
replication without taking into account the power of
the second sample to replicate the findings. The
power of DNA pooling with the second design is 4, 16
and 47% for ORs of 1.2, 1.3 and 1.5, respectively.
For this design and with these ORs the reduction in
power ranges between 41 and 79% compared to
individual genotyping.
Pooling and individual genotyping
We screened 2054 extreme scoring individuals in
eight DNA pools for an association with neuroticism
(Figure 1). We calculated an association log P value
for 452 574 SNPs (with MAF > 5%) based on the
frequency differences between high and low N pools,
Table 1 Power of DNA pooling strategy compared to
individual genotyping
OR Functional
SNP (%)
Individual
genotyping (%)
DNA
pooling (%)
5% threshold
1.2 0 0 0
1.3 6 4 3
1.5 51 41 31
1.7 80 68 56
2 93 82 72
3 99 90 85
Log P > 3
1.2 19 19 4
1.3 53 49 16
1.5 88 80 47
1.7 97 90 66
2 99 92 76
3 100 95 87
Abbreviations: OR, odds ratio; SNP, single-nucleotide
polymorphism; 5% threshold, power to detect the associa-
tion with significance above the 5% genome-wide thresh-
old; log P > 3, percentage of cases with log P > 3, in a design
that includes testing the log P > 3 SNPs in a replication
sample.
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the SNP allele frequency and the SNP-specific
measurement error. SNPs with MAF below 0.05 were
excluded because of the limited power to detect a
significant association and the decrease in the accu-
racy of DNA pooling with rare variants. We ranked the
SNPs based on the log P values and used a log P > 4 as
the cutoff for individual genotyping. We excluded 78
SNPs because the allele frequency estimates had been
biased by an outlier in one of the pools. Four hundred
and forty SNPs were considered for individual
genotyping. Out of 440 SNPs, the assays of 405 SNPs
were successfully designed and were used to genotype
a subset of the sample (759 individuals). We calcu-
lated the significance for allele frequency differences
between high and low N for sex-averaged and sex-
specific frequencies for each SNP. Forty-two SNPs
(10%) had a P-value between 0.05 and 0.01, and 28
SNPs (7%) had a P-value < 0.01. We genotyped the
whole sample with 110 SNPs that showed sex-specific
or sex-averaged P-values < 0.1. No SNP had a P-value
that remained significant after correcting for multi-
ple testing (300 000 tests). Eighteen SNPs had a P-value
< 103, three SNPs had a P-value < 104 and two had
a P-value < 105. As expected, our results using DNA
pooling (with a log P > 4 as cutoff) produced a
significant deficiency in P-values < 103 compared
to what would be expected by chance if all SNPs
were individually genotyped (B300 expected by
chance). However, we do not see a significant
deficiency of P-values < 105 (B3 expected by
chance), which indicates that our method would
have potentially picked SNPs with genome-wide
significant values after Bonferroni correction for
multiple tests (P-values < 0.05/300 000 = 1.67107).
The highest scoring SNPs and their associated genes
are shown in Table 2.
Haplotype analysis
To examine the possibility that multiple SNPs, each
of small effect, might lie within the same gene, we
searched for genes or intervals of 50 kb or less
containing one SNP with a log P greater than 4 (based
on the pooling analysis) and at least one other SNP
with a log P greater than 2. Since LD would explain
the presence of clusters of SNPs with high log
P values, we excluded the pairs of SNPs whose r2
values (from the HapMap project) were greater than
0.6. We identified 81 SNPs from 34 regions for
individual genotyping. Nineteen clustered SNPs
showed a P-value < 0.05 and eight SNPs a P-value
< 0.01 (Table 3). From each region we selected three
SNPs (or two when three could not be found) with the
most significant P-values for haplotype analysis
since, in some situations, haplotype analysis is
statistically more powerful.35 We compared the mini-
mum P-value obtained from the single SNP analysis
and the minimum P-value obtained from the haplo-
type analysis (global and haplotype-specific ana-
lyses). The minimum P-value from the haplotype
analysis was substantially lower ( < 0.5) in only two
cases than that obtained from single marker analysis.
The analysis of three SNP haplotypes (rs702543,
rs17782374 and rs35277) of the PDE4D gene gave a
simulated P-value for the maximum haplotype-
specific score statistics of 0.00022 relative to a
minimum P-value of 0.00082 for the single SNP
analysis. The analysis of two SNP haplotypes
(rs17225638 and rs11177914) at the RAB3IP gene
gave a simulated P-value for the global statistics of
0.0069 relative to a minimum P-value of 0.020 for the
single SNP analysis.
Distribution of P-values obtained in the DNA pooling
stage in linkage regions
To enhance the power to detect association in regions
where we had prior information for a genetic effect,
we took into account evidence from a previous
linkage scan that used the same population analyzed
here by association.27 Analysis of allele sharing in
discordant and concordant sib pairs previously
identified five significant quantitative trait loci
(QTLs) for neuroticism, on 1q, 4q, 7p, 12q and 13q.
We tested whether the distribution of P-values
obtained in the DNA pooling stage was higher than
expected in the QTL regions.
We calculated the total proportion of log P values
above 2, 3, 4 and 5 in the 1-LOD score intervals for the
five significant peaks. The proportion of log P values
greater than 2, 3, 4 and 5 was also calculated in a set
of five regions of the same size chosen at random from
across the genome, and this process was repeated
1000 times. We found no significant enrichment in
the 1-LOD score intervals of the QTL regions, when
analyzed together. However, when we tested indivi-
dual regions (comparing the proportion of log
P values above a certain value in each 1-LOD score
interval compared to random selected region), we
found a nominally significant (P = 0.022) enrichment
in log P > 2 values in the 1-LOD interval on chromo-
some 1q. This result becomes non-significant when
corrected for multiple testing.
Age and sex regressed scores
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Figure 1 Distribution of N scores as standardized residuals
of the sum scores after regression on age and sex (88 141
individuals). The selection of individuals with extreme
score is presented below the histogram. The black ticks
mark the sample used in the DNA pools, and the gray
represents the sample used in the replication sample.
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Copy number variants
We noticed that some SNPs with high log P values in
the DNA pooling experiment are clustered in regions
of known copy number variation (CNV). In the DNA
pooling experiment we calculated the association
score using the relative intensities of the probes,
which might be influenced by CNVs. Hence, a cluster
of high log P values could be a result of different
frequencies of CNVs in cases and controls rather than
of SNP allele frequency differences. We tested the
distribution of log P values in regions of known CNVs
and random regions of the same size (in the same way
as we investigated the distribution of log P values in
the linkage regions). We observed a positive enrich-
ment of log P values in CNVs obtained from The
Database of Genomic Variants, http://projects.tcag.ca/
variation/ (not including the data from Redon et al.36)
(P = 0.0085, 0.017, 0.024 and 0.031 for log P of 2, 3, 4
and 5). We also tested the distribution of log P values
in CNVs reported recently.36 We examined CNVs
identified using the 500 K EA arrays with a frequency
of greater than 5%. The positive enrichment of log
P values using this dataset was even more significant
(P = 0.017, 0.003, 0.002 and P < 0.001 for log P of 2, 3,
4 and 5).
We considered whether this result could be
artifactual. Within CNVs, the amount of DNA added
to each pool might be more variable than in other
regions, so we expect first that there will be more
variation in allele frequency estimates in these
regions and second that the differences between
groups (as measured by the log P values) will be less
when frequencies are obtained by individual geno-
typing.
Neither expectation was realized. Variation be-
tween DNA pools at SNPs within CNVs was not
significantly different from that seen at SNPs else-
where in the genome, and the enrichment of high log
P values at CNVs was also seen in some cases in
individually genotyped SNPs. These results indicate
that the explanation for the enrichment may be
related to the biology of neuroticism.
We examined each CNV to identify those contribut-
ing most to the observed enrichment of log P values. A
region on chromosome 17q21.31 is the CNV region
with the highest enrichment of high log P values
Table 2 Results of individual genotyping
SNP DNA
pooling
ranka
P-values for allele frequencies differences
SNP
identifier
Geneb Chrc Position Genotypingd Replicatione
All M F All M F
rs322239 PTN 7 136413862 12 4.8E06 1.1E04 5.7E03 8.8E01 7.4E01 6.5E01
rs4841017 8 8614503 53 6.5E06 2.3E05 1.5E02 2.3E01 3.7E01 4.1E01
rs17385253 1 34564102 21 3.3E05 7.7E03 1.5E03 2.8E01 1.3E01 8.5E01
rs9329165f 8 8614052 160 3.8E05 3.0E05 4.9E02 2.1E01 9.4E01 9.5E02
rs10483573 14 46932227 258 5.6E05 3.6E03 3.2E03 6.1E01 7.8E01 3.9E01
rs10504830 CNBD1 8 88448321 115 1.1E04 6.8E04 2.2E02 5.7E01 1.4E01 6.8E01
rs13290746g 9 34858377 146 1.5E04 3.6E02 1.6E03 3.8E01 2.8E01 7.8E01
rs9959800 18 52115138 48 1.7E04 1.1E02 6.0E03 1.4E01 8.0E01 3.8E02
rs10797812 1 179716254 159 2.4E04 2.2E02 4.1E03 5.1E01 2.6E01 7.2E02
rs4875610 CSMD1 8 3165318 430 4.1E04 2.6E02 6.3E03 6.5E01 4.7E01 9.9E01
rs2123315f 4 18642838 136 4.3E04 2.0E01 3.8E03 9.6E02 5.1E01 1.3E01
rs702543 PDE4D 5 58878531 184 8.2E04 9.8E04 9.5E02 7.7E04 2.7E01 5.9E04
rs7666238 4 142453368 315 9.0E04 2.1E03 6.9E02 6.1E01 1.8E01 7.9E02
rs9431663 TRIM67 1 227620956 211 1.2E03 8.2E01 1.2E04 9.7E01 8.6E02 1.6E01
rs7594674g 2 67191611 432 2.6E03 4.3E01 6.5E04 3.9E01 4.0E01 7.9E02
rs873989 DAB1 1 58268619 148 3.5E03 8.2E01 1.3E04 9.3E01 4.9E01 5.2E01
rs401897 C20orf32 20 54463165 394 5.6E03 6.5E04 3.4E01 5.2E01 8.3E01 4.4E01
rs201997 ADAM18 8 39703325 186 6.4E03 2.7E04 5.3E01 1.2E01 6.0E02 6.4E01
rs1452788 TCF4 18 51268302 384 6.5E03 6.7E01 9.3E04 5.7E01 3.9E01 9.7E01
Abbreviation: SNPs, single-nucleotide polymorphisms.
SNPs within a copy number variation region are in bold.
aRank of SNPs based on log P results from the DNA pooling experiment.
bSNP associate gene based on NCBI dbSNP.
cChromosome.
dResults from individual genotyping the sample in the pools.
eResults from genotyping the replication sample.
fGenotyping distribution deviates from Hardy–Weinberg equilibrium in sample included in the pools (P-value < 0.0026).
gGenotyping distribution deviates from Hardy–Weinberg equilibrium in both samples using two different SNP genotyping
platforms (iPLEX and HME).
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(Figure 2). The enrichment of log P values in other
CNVs is no longer significant when chromosome 17 is
excluded from the analysis (minimum P = 0.087 for
log P = 5). Individual genotyping of the sample used
in the pools with an SNP (rs10514901) within the
CNV region showed a modest association with
neuroticism (P = 0.0094).
Replication
We attempted to replicate the results of the most
significant SNPs in an independent sample. Nineteen
SNPs with a P-value < 0.001 (sex-specific or sex-
averaged) were genotyped on a sample that consisted
of 933 women and 601 men (all in the 10% low or
high tail of the N distribution) (Figure 1). Only one
SNP showed a statistically significant association in
the replication. The significant SNP, rs702543, had a
P-value of 0.00081 in the original sample, a P-value
of 0.00078 (Bonferroni corrected P-value with 19
tests = 0.015) in the replication sample and a com-
bined P-value = 2 106. In both the samples the
frequency of the A allele was increased in the high
Table 3 Haplotype analysis
Genea Chrb Position SNP1 SNP2 SNP3 SNP min Pc Global sim Pd Max-stat sim Pe
LOC284661 1 4370062 rs6679220 rs349410 4.2E02 2.1E01 1.9E01
DAB1 1 58268619 rs873989 rs1213659 rs1202835 1.3E04 1.5E02 3.9E02
NRXN1 2 50761056 rs7576283 rs1037426 rs930295 1.0E01 7.2E01 7.3E01
CTNNA2 2 80715942 rs216617 rs3770369 rs7609261 2.9E03 3.6E02 1.2E01
DPP10 2 116252992 rs10496506 rs11123306 2.1E01 5.4E01 8.2E01
LRP1B 2 140847651 rs13021003 rs2046563 rs17551974 1.5E02 8.6E02 2.9E02
FHIT 3 60694463 rs17361653 rs1882899 rs1716741 1.3E03 8.6E04 1.9E02
NA 3 153382923 rs641025 rs989920 rs325738 2.6E03 2.6E03 8.7E03
NA 3 162481199 rs7652267 rs1478565 8.3E02 1.3E01 1.4E01
NLGN1 3 175393516 rs6806890 rs6779246 rs7623402 1.6E02 7.2E02 1.1E02
NA 4 116523708 rs1112531 rs963251 5.1E02 3.6E01 6.4E01
PDE4D 5 58878531 rs702543 rs17782374 rs35277 8.2E04 4.7E04 2.2E04
NA 6 33080668 rs592625 rs7743563 rs2523666 6.9E02 4.2E01 1.9E01
NA 6 120286484 rs10484965 rs10499094 rs9320695 7.3E03 1.3E01 3.7E01
LAMA2 6 129281463 rs7776116 rs9321142 rs6928495 1.1E03 3.4E02 5.9E03
PARK2 6 162539612 rs6904579 rs3019449 rs17649761 1.6E03 4.1E02 1.9E02
LOC442275 6 164461465 rs206694 rs2764649 4.3E02 8.1E02 5.0E02
CREB5 7 28296787 rs4722801 rs177582 3.7E02 9.0E02 1.3E01
NA 7 95721578 rs2724041 rs2524976 6.9E03 6.5E02 1.0E01
RELN 7 102871243 rs362698 rs17321820 rs1541329 2.4E02 3.0E01 2.6E01
PTN 7 136413862 rs322239 rs322323 rs322236 4.8E06 8.0E05 1.0E05
NA 8 8614503 rs4841017 rs9329165 rs6601729 6.5E06 1.9E04 1.7E04
CSMD1 8 3178277 rs4395910 rs10503232 rs4875610 4.1E04 8.5E04 6.2E04
NRG1 8 32336767 rs1487152 rs7002732 rs12114401 4.6E04 4.1E04 3.0E03
NA 8 108959180 rs1389976 rs10505119 1.9E02 7.9E02 3.2E02
CSMD3 8 114031134 rs10505196 rs4876501 rs10505174 2.2E02 2.0E01 4.4E01
PTPRD 9 8481878 rs6477311 rs1359114 rs10511494 1.2E02 7.5E02 3.1E02
ASTN2 9 116859364 rs2418446 rs10513281 rs10983238 3.4E02 2.2E01 4.1E01
TMEM16C 11 26402767 rs10834976 rs1381181 rs10834971 4.4E03 1.4E02 2.7E02
BDNF 11 27715568 rs985205 rs2049045 1.7E01 4.3E01 3.6E01
DLG2 11 84283401 rs17147761 rs891773 rs10501548 4.4E02 3.7E01 4.9E01
CNTN5 11 98413115 rs10501893 rs10501898 rs10501903 4.1E02 4.9E02 6.2E02
GRIP1 12 65150558 rs4913307 rs12314237 rs12581890 1.2E02 1.1E02 2.0E02
RAB3IP 12 68480702 rs17225638 rs11177914 2.0E02 6.9E03 1.5E02
LOC284058 17 41550514 rs10514901 rs17631303 rs2532276 9.4E03 6.7E02 2.2E02
TCF4 18 51268302 rs1452788 rs12326693 rs9957668 9.3E04 2.8E01 3.2E01
NA 18 52115138 rs9959800 rs1229587 1.7E04 1.5E03 1.4E03
GRIK1 21 30306168 rs2832533 rs2832438 5.4E03 1.0E02 1.0E02
ERG 21 38888946 rs17194186 rs2836502 rs2836365 2.2E02 2.4E02 1.8E02
Abbreviation: NA, not available.
SNPs within a copy number variation region are in bold.
aSNP associate gene based on NCBI dbSNP.
bChromosome.
cMinimum P-value from the single SNP analysis.
dSimulation P-value for the global score statistic.
eSimulation P-value for the maximum score statistic.
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Ns (frequency in the combined sample = 0.61) relative
to the low Ns (frequency = 0.55) with an OR of 1.27
(95% confidence interval for the OR (95% CI) is 1.15–
1.4) and proportion of variance explained of 0.64% in
an ANOVA model. Using the age and sex regressed N
score to analyze the replication sample we obtain a
P-value of 0.00065 for the additive model (note that
because the scores are so extreme in the selected
samples, this result is almost identical to the value
obtained by applying a w2 test: P = 0.00078). The ORs
for men (OR = 1.30 in the combined sample) and
women (OR = 1.25) were not statistically different in
the pooling sample, the replication sample or the
combined sample.
We attempted to replicate rs702543 in other
populations. We investigated three populations: (1)
a sample selected from 15 027 Australian twins
and 11 389 of their family members. Unrelated
individuals with neuroticism, anxiety and depression
scores in the upper or lower deciles were genotyped
(n = 761)37; (2) unrelated individuals from the Virginia
Adult Twin Study of Psychiatric and Substance Use
Disorders.38 We used a sample of 1022 individuals
selected from 9270 twins for a study of candidate
genes on anxiety, depression and neuroticism; (3)
a sample of 417 unrelated individuals from the
Netherlands twin family for a study of anxious
depression.39 Individuals were selected from a total
of 13 717 individuals from 3344 families on the basis
of extreme factor scores. The factor score included
a neuroticism assessment, using the Amsterdamse
Biografische Vragenlijst (ABV), a self-report person-
ality instrument similar in content to the EPQ.40,41
We divided the samples from all populations into
two groups based on N scores. We analyzed the allele
and genotype frequencies in high and low N in each
population and also in the combined sample (Table
4). The combined sample from the three populations
showed a non-significant trend for an excess of the
A allele in high N-score group (OR = 1.05, 95%
CI = 0.92–1.19, P = 0.46). The allelic effect of SNP
rs702543 estimated from the combination of the three
populations and our replication sample in terms of
OR is 1.13 (95% CI = 1.03–1.24, P = 0.012).
We also used family based analysis to test for the
association of rs702543 with neuroticism in the
Netherlands and Australian full family samples.
There was no evidence for association in the Nether-
lands family sample (N = 1148, wave 6, analyzed
using quantitative transmission-disequilibrium test
(QTDT), P = 0.88). The Australian family sample was
analyzed using the age and sex transformed scores42
based on the full 23-item EPQ-R N scale and the
10-item Kessler Psychological Distress scale43 (K10),
a measure of current non-specific psychological
distress in the anxiety–depression spectrum. Indivi-
duals were considered ‘affected’ for EPQ-R and K10 if
their residual scores were in the top 5, 10, 15 and 20
percentile of available residuals. Consistent with the
findings in the original sample, an overtransmission
of the A allele to affected individuals was observed
for all percentiles. The most significant transmission
distortion was observed when the individuals in
the 20 percentile were treated as affected (analyzed
using UNPHASED v3.03, EPQ P-value = 0.040, K10
P-value = 0.0059).
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Figure 2 DNA pooling association results in a region of
chromosome 17q21.31. Results of the DNA pooling are
presented in log P values (vertical axis). The gray bars show
the positions in megabases (Mb) of copy number variations
(CNVs) on 17q21.3.36
Table 4 Genotypes in replication samples
Sample High N Low N OR P allele P genotype
AA AG GG A%a N AA AG GG A% N
Pool sample 348 428 156 60.3 932 291 468 197 54.9 956 1.25 0.00082 0.0035
Our replication 289 316 123 61.4 728 197 305 133 55.0 635 1.3 0.00077 0.0029
Australian 129 163 57 60.3 349 144 196 71 58.9 411 1.06 0.57 0.85
Dutch 75 84 31 62.0 190 85 106 36 61.0 227 1.03 0.82 0.88
Virginia 83 132 38 58.9 253 261 379 129 58.6 769 1.01 0.90 0.69
Three groups 287 379 126 60.2 792 490 681 236 59.0 1407 1.05 0.46 0.76
All replications 576 695 249 60.8 1520 687 986 369 57.8 2042 1.13 0.012 0.029
Abbreviation: OR, odds ratio.
aFrequency of the A allele.
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Discussion
We have performed the first whole genome analysis of
neuroticism, using pooled DNA. We show that, by
using eight pools with five replicates of each, we
retain between 21 and 94% (depending on the effect
size and threshold used) of the power from genotyp-
ing all 452 574 SNPs individually, equivalent to a
50-fold saving in the costs. We identified one SNP
rs702543 from an analysis of B2000 individuals
selected from the neuroticism extremes of 88 142
people, which we were able to replicate in a separate
sample from the same cohort. The SNP was geno-
typed in three other laboratories, on related, but not
identical, phenotypes. In each case the direction of
allelic effects was the same as in our sample, but the
test reached statistical significance in only one
sample, that is, only in one method of analysis
(family based analysis). Our study raises a number
of issues for whole genome association studies in
general and the genetic basis of neuroticism in
particular.
We deal first with the performance of the pooling
strategy. Our estimates of the power of our DNA
pooling strategy were derived by simulation using the
measurement error across all SNPs from both 500 and
100 K arrays. However, there is a 3.2-fold difference
between the variances of the repeated measurements
for the two types of arrays (mean variance for
100 K = 0.0017, and for 500 K = 0.0055). This differ-
ence in measurement accuracy is probably due to the
smaller number of features per SNP and the reduction
in feature size in the 500 K array relative to the
100 K.21 It means that the measurements in the 500 K
arrays should be at least triplicated to achieve the
genotype accuracy obtained with the 100 K arrays.
DNA pooling allows substantial savings in geno-
typing costs (see, for example, references44–46) and
there have been successes using DNA pooling in the
analysis of a relatively small number of markers, for
example, in schizophrenia47,48 multiple sclerosis,49
and serum high-density lipoprotein cholesterol
levels.50,51 However, in the two cases where whole
genome association has been attempted (that is, in
memory52 and mild mental impairment53), the yields
have been low, that is, in both cases only one locus
was considered significant.
Our results are comparable, in that we have found
just one locus of small effect. Failure to replicate the
finding in all samples is not unexpected, given the
differences between the cohorts, in both phenotype
and recruitment. No sample used exactly the same
phenotype. We used the 23-item Eysenck N scale,
while the US and Australian sample used the short
(12-item) scale and the Dutch sample used the
Amsterdamse Biografische Vragenlijst, which is based
on the Eysenck scale but is not identical. However,
differences in the measures are likely to be out-
weighed by differences in the recruitment strategy.
Our sample represents the extremes of about 61 367
unrelated people, the Dutch from 3444 families, the
Australian from around 7500 families and the US
from 9270 twins.
Second, we consider the lessons for the design of
whole genome association studies. Assuming that the
genetic basis of neuroticism is typical of behavior, and
also typical of other complex traits, our results
reinforce the findings that the ORs of most complex
trait loci are less than 1.6.54 Our linkage study on the
same cohort failed to find any large effect loci
(explaining more than 5% of the variance), and given
that we had approximately 50% power to detect an
OR of 1.5 (which is equivalent to a locus explaining
0.5–1% of the variance) and failed to find any loci
accounting for more than 1% of the variance, it seems
likely that the 40% additive genetic variance of
neuroticism arises from many loci explaining much
less than 1%. This means that to obtain adequate
power in whole genome association studies, much
larger samples will be needed than anticipated.
Using association analysis, we failed to identify any
genes under the five significant linkage peaks that
were obtained using the sib pairs from the same
population-based study of personality (although it
should be noted that there was a nominally signifi-
cant enrichment in log P > 2 values in the 1-LOD
interval on chromosome 1q). Our significant SNP is
located on chromosome 5, a region that was not
indicated by the linkage analysis. Since linkage
analysis is robust to allelic heterogeneity at a locus,
this may indicate that rare variants are a major
contributor to the heritability of neuroticism. The
linkage signal could also be due to the co-localization
under the linkage peaks of variants in different genes,
each of too insufficient individual effect to be
detected by association. Other possible factors that
could contribute to the lower power of our study to
identify the genes under the linkage peaks include the
effect of incomplete genome coverage (low LD
between the SNPs typed and the causal variants)
and a high false-negative rate of the association
analysis.
Unlike the linkage intervals that did not show a
significant enrichment of high log P values, we did
see the enrichment in known CNVs. Chromosomal
abnormalities have been reported in patients with
schizophrenia, bipolar disorder and major depres-
sion,55,56 but it is not clear to what extent CNVs
contribute to variation in behavior. It is noteworthy
that CNVs on chromosome 17 (enriched for high log P
values) contain two genes involved in behavior, that
is, the Tau gene (MAPT) and the corticotropin-
releasing hormone receptor-1 (CRHR1). CRHR1 has
been shown to mediate anxiety-related behavior and
hormonal adaptation to stress.57
Finally, our findings are important for the under-
standing of the genetic basis of neuroticism and
the associated psychiatric disorders of anxiety and
depression. The rs702543 SNP is located in the
phosphodiesterase 4D, cAMP-specific (PDE4D) gene,
in an intron between exon D3 and D8. The HapMap
database (CEU, Release #21) shows one SNP
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(rs702542) in complete correlation with rs702543,
and two other SNPs that are partially correlated, that
is, rs296410 (r2 = 0.5) and rs40216 (r2 = 0.56). All three
SNPs lie within a 65.3-kb haplotype block on
chromosome 5 (58 872 707–58 937 990 bp). The G
allele of rs702543 creates a putative cAMP response
element (CRE) for CREB2/c-jun heterodimer
(TGACGTTA), while the A allele destroys it.58,59 The
transcription of different isoforms of PDE4D was
shown to be regulated by cAMP levels. For example,
a CRE (TGACGTT) in the promoter of an isoform of
PDE4D (PDE4D5) was shown to be involved in the
cAMP responsiveness of the PDE4D5 promoter.60
Several other lines of evidence support the involve-
ment of the PDE4D gene in susceptibility to neuroti-
cism and depression. A PDE4-specific inhibitor
rolipram has antidepressant effects on animals and
patients with major depression.61–63 PDE4D knockout
mice show antidepressant-like behavior, which is
further increased by the antidepressants desipramine
and fluoxetine but not by rolipram. This suggests that
the PDE4D subtype is an essential mediator of the
antidepressant effects of rolipram. PDE4D expression
is increased in mouse cerebral cortex by the repeated
treatment with desipramine, fluoxetine and rolipram
and in the hippocampus by fluoxetine and rolipram.
Recently, variants in two genes encoding PDEs were
found to be associated with the diagnosis of major
depression, and one of them (PDE11A) was also found
to be associated with remission in response to
antidepressants.64 Together, these observations indi-
cate that the PDE4D gene is likely to be involved in
susceptibility to neuroticism and the associated
psychiatric disorders of major depression and anxiety.
Acknowledgments
Funding for this work was provided by the Wellcome
Trust. SS is supported by the European Molecular
Biology Organization.
References
1 Eysenck HJ. The Biological Basis of Personality. Thomas: Spring-
field, IL, 1967.
2 Angst J, Clayton P. Premorbid personality of depressive, bipolar
and schizophrenic patients with special reference to suicidal
issues. Compr Psychiatry 1986; 27: 511–532.
3 Boyce P, Parker G, Barnett B, Cooney M, Smith F. Personality as a
vulnerability factor to depression. Br J Psychiatry 1991; 159:
106–114.
4 Hirschfeld RM, Klerman GL, Lavori P, Keller MB, Griffith P,
Coryell W. Premorbid personality assessments of first onset of
major depression. Arch Gen Psychiatry 1989; 46: 345–350.
5 Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. A
longitudinal twin study of personality and major depression in
women. Arch Gen Psychiatry 1993; 50: 853–862.
6 Bienvenu OJ, Samuels JF, Costa PT, Reti IM, Eaton WW, Nestadt G.
Anxiety and depressive disorders and the five-factor model of
personality: a higher- and lower-order personality trait investiga-
tion in a community sample. Depress Anxiety 2004; 20: 92–97.
7 Cox BJ, MacPherson PS, Enns MW, McWilliams LA. Neuroticism
and self-criticism associated with posttraumatic stress disorder
in a nationally representative sample. Behav Res Ther 2004; 42:
105–114.
8 Jylha P, Isometsa E. The relationship of neuroticism and extraver-
sion to symptoms of anxiety and depression in the general
population. Depress Anxiety 2006; 23: 281–289.
9 Jylha P, Isometsa E. Temperament, character and symptoms of
anxiety and depression in the general population. Eur Psychiatry
2006; 21: 389–395.
10 Hettema JM, Neale MC, Myers JM, Prescott CA, Kendler KS. A
population-based twin study of the relationship between neuroti-
cism and internalizing disorders. Am J Psychiatry 2006; 163:
857–864.
11 Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive
developmental model for major depression in women. Am
J Psychiatry 2002; 159: 1133–1145.
12 Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive
developmental model for major depression in men. Am
J Psychiatry 2006; 163: 115–124.
13 Kendler KS, Gatz M, Gardner CO, Pedersen NL. Personality and
major depression: a Swedish longitudinal, population-based twin
study. Arch Gen Psychiatry 2006; 63: 1113–1120.
14 Fullerton J, Cubin M, Tiwari H, Wang C, Bomhra A, Davidson S
et al. Linkage analysis of extremely discordant and concordant
sibling pairs identifies quantitative-trait loci that influence
variation in the human personality trait neuroticism. Am J Hum
Genet 2003; 72: 879–890.
15 Nash MW, Huezo-Diaz P, Williamson RJ, Sterne A, Purcell S,
Hoda F et al. Genome-wide linkage analysis of a composite index
of neuroticism and mood-related scales in extreme selected
sibships. Hum Mol Genet 2004; 13: 2173–2182.
16 Neale BM, Sullivan PF, Kendler KS. A genome scan of neuroticism
in nicotine dependent smokers. Am J Med Genet B Neuropsychiatr
Genet 2005; 132: 65–69.
17 Ioannidis JP, Trikalinos TA, Khoury MJ. Implications of small
effect sizes of individual genetic variants on the design and
interpretation of genetic association studies of complex diseases.
Am J Epidemiol 2006; 164: 609–614.
18 Darvasi A, Soller M. Selective DNA pooling for determination of
linkage between a molecular marker and a quantitative trait locus.
Genetics 1994; 138: 1365–1373.
19 Butcher LM, Meaburn E, Liu L, Fernandes C, Hill L, Al-Chalabi A
et al. Genotyping pooled DNA on microarrays: a systematic
genome screen of thousands of SNPs in large samples to detect
QTLs for complex traits. Behav Genet 2004; 34: 549–555.
20 Craig I, Meaburn E, Butcher L, Hill L, Plomin R. Single-nucleotide
polymorphism genotyping in DNA pools. Methods Mol Biol 2005;
311: 147–164.
21 Kirov G, Nikolov I, Georgieva L, Moskvina V, Owen MJ,
O’Donovan MC. Pooled DNA genotyping on Affymetrix SNP
genotyping arrays. BMC Genomics 2006; 7: 27.
22 Macgregor S, Visscher PM, Montgomery G. Analysis of pooled
DNA samples on high density arrays without prior knowledge of
differential hybridization rates. Nucleic Acids Res 2006; 34: e55.
23 Meaburn E, Butcher LM, Schalkwyk LC, Plomin R. Genotyping
pooled DNA using 100K SNP microarrays: a step towards
genomewide association scans. Nucleic Acids Res 2006; 34: e27.
24 Willis-Owen SA, Turri MG, Munafo MR, Surtees PG, Wainwright NW,
Brixey RD et al. The serotonin transporter length polymorphism,
neuroticism, and depression: a comprehensive assessment of associa-
tion. Biol Psychiatry 2005; 58: 451–456.
25 Willis-Owen SA, Shifman S, Copley RR, Flint J. DCNP1: a novel
candidate gene for major depression. Mol Psychiatry 2006; 11:
121–122.
26 Willis-Owen SA, Fullerton J, Surtees PG, Wainwright NW,
Miller S, Flint J. The Val66Met coding variant of the brain-derived
neurotrophic factor (BDNF) gene does not contribute toward
variation in the personality trait neuroticism. Biol Psychiatry 2005;
58: 738–742.
27 Martin N, Goodwin G, Fairburn C, Wilson R, Allison D, Cardon LR
et al. A population based study of personality in 34 000 sib-pairs.
Twin Res 2000; 3: 310–315.
28 Eysenck HJ, Eysenck SBG (eds). Manual of the Eysenck Personality
Questionnaire. Educational and Industrial Testing Service: San
Diego, CA, 1975.
Whole genome association of neuroticism
S Shifman et al
311
Molecular Psychiatry
29 Aluja A, Garcı´a O, Garcia LF. A comparative study of Zuckerman’s
three structural models for personality through the NEO-PI-R:
ZKPQ-III-R, EPQ-RS and Goldberg’s 50-bipolar adjectives. Pers
Individ Dif 2002; 33: 713–725.
30 De Fruyt F, Van De Wiele L, Van Heeringen C. Cloninger’s
psychobiological model of temperament and character and
the five-factor model of personality. Pers Individ Dif 2000; 29:
441–452.
31 Shifman S, Pisante-Shalom A, Yakir B, Darvasi A. Quantitative
technologies for allele frequency estimation of SNPs in DNA
pools. Mol Cell Probes 2002; 16: 429–434.
32 Meaburn E, Butcher LM, Liu L, Fernandes C, Hansen V, Al-Chalabi
A et al. Genotyping DNA pools on microarrays: tackling the QTL
problem of large samples and large numbers of SNPs. BMC
Genomics 2005; 6: 52.
33 Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ,
Donnelly P. A haplotype map of the human genome. Nature 2005;
437: 1299–1320.
34 Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA.
Score tests for association between traits and haplotypes
when linkage phase is ambiguous. Am J Hum Genet 2002; 70:
425–434.
35 Schaid DJ. Evaluating associations of haplotypes with traits. Genet
Epidemiol 2004; 27: 348–364.
36 Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD
et al. Global variation in copy number in the human genome.
Nature 2006; 444: 444–454.
37 Kirk KM, Birley AJ, Statham DJ, Haddon B, Lake RI, Andrews JG
et al. Anxiety and depression in twin and sib pairs extremely
discordant and concordant for neuroticism: prodromus to a
linkage study. Twin Res 2000; 3: 299–309.
38 Hettema JM, An SS, Neale MC, Bukszar J, van den Oord EJ,
Kendler KS et al. Association between glutamic acid decarbox-
ylase genes and anxiety disorders, major depression, and neuroti-
cism. Mol Psychiatry 2006; 11: 752–762.
39 Boomsma DI, Beem AL, van den Berg M, Dolan CV, Koopmans JR,
Vink JM et al. Netherlands twin family study of anxious
depression (NETSAD). Twin Res 2000; 3: 323–334.
40 Middeldorp CM, Birley AJ, Cath DC, Gillespie NA, Willemsen G,
Statham DJ et al. Familial clustering of major depression and
anxiety disorders in Australian and Dutch twins and siblings.
Twin Res Hum Genet 2005; 8: 609–615.
41 Rettew DC, Vink JM, Willemsen G, Doyle A, Hudziak JJ, Boomsma DI.
The genetic architecture of neuroticism in 3301 Dutch adolescent
twins as a function of age and sex: a study from the Dutch twin
register. Twin Res Hum Genet 2006; 9: 24–29.
42 Jardine R, Martin NG, Henderson AS. Genetic covariation between
neuroticism and the symptoms of anxiety and depression. Genet
Epidemiol 1984; 1: 89–107.
43 Kessler R, Mroczek D. Final Version of the Psychological Distress
Scale. Technical Note. Institute for Social Research, University of
Michigan: Ann Arbor, MI, 1994.
44 Sham P, Bader JS, Craig I, O’Donovan M, Owen M. DNA pooling:
a tool for large-scale association studies. Nat Rev Genet 2002; 3:
862–871.
45 Mohlke KL, Erdos MR, Scott LJ, Fingerlin TE, Jackson AU,
Silander K et al. High-throughput screening for evidence of
association by using mass spectrometry genotyping on DNA pools.
Proc Natl Acad Sci USA 2002; 99: 16928–16933.
46 Barratt BJ, Payne F, Rance HE, Nutland S, Todd JA, Clayton DG.
Identification of the sources of error in allele frequency estima-
tions from pooled DNA indicates an optimal experimental design.
Ann Hum Genet 2002; 66: 393–405.
47 Norton N, Williams HJ, Williams NM, Spurlock G, Zammit S,
Jones G et al. Mutation screening of the Homer gene family and
association analysis in schizophrenia. Am J Med Genet B
Neuropsychiatr Genet 2003; 120: 18–21.
48 Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A,
Lev-Lehman E, Weizman A et al. A highly significant association
between a COMT haplotype and schizophrenia. Am J Hum Genet
2002; 71: 1296–1302.
49 Sawcer S, Maranian M, Setakis E, Curwen V, Akesson E, Hensiek A
et al. A whole genome screen for linkage disequilibrium in
multiple sclerosis confirms disease associations with regions
previously linked to susceptibility. Brain 2002; 125: 1337–1347.
50 Bansal A, van den Boom D, Kammerer S, Honisch C, Adam G,
Cantor CR et al. Association testing by DNA pooling: an effective
initial screen. Proc Natl Acad Sci USA 2002; 99: 16871–16874.
51 Hinds DA, Seymour AB, Durham LK, Banerjee P, Ballinger DG,
Milos PM et al. Application of pooled genotyping to scan
candidate regions for association with HDL cholesterol levels.
Hum Genomics 2004; 1: 421–434.
52 Papassotiropoulos A, Stephan DA, Huentelman MJ, Hoerndli FJ,
Craig DW, Pearson JV et al. Common Kibra alleles are associated
with human memory performance. Science 2006; 314: 475–478.
53 Butcher LM, Meaburn E, Knight J, Sham PC, Schalkwyk LC,
Craig IW et al. SNPs, microarrays and pooled DNA: identification
of four loci associated with mild mental impairment in a sample of
6000 children. Hum Mol Genet 2005; 14: 1315–1325.
54 Ioannidis JP, Trikalinos TA, Khoury MJ. Implications of small
effect sizes of individual genetic variants on the design and
interpretation of genetic association studies of complex diseases.
Am J Epidemiol 2006; 164: 609–614.
55 Lee JA, Lupski JR. Genomic rearrangements and gene copy-
number alterations as a cause of nervous system disorders. Neuron
2006; 52: 103–121.
56 Wilson GM, Flibotte S, Chopra V, Melnyk BL, Honer WG, Holt RA.
DNA copy-number analysis in bipolar disorder and schizophrenia
reveals aberrations in genes involved in glutamate signaling. Hum
Mol Genet 2006; 15: 743–749.
57 Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH
et al. Corticotropin releasing factor receptor 1-deficient mice display
decreased anxiety, impaired stress response, and aberrant neuroen-
docrine development. Neuron 1998; 20: 1093–1102.
58 Benbrook DM, Jones NC. Heterodimer formation between CREB
and JUN proteins. Oncogene 1990; 5: 295–302.
59 Benbrook DM, Jones NC. Different binding specificities and
transactivation of variant CRE’s by CREB complexes. Nucleic
Acids Res 1994; 22: 1463–1469.
60 Le Jeune IR, Shepherd M, Van Heeke G, Houslay MD, Hall IP.
Cyclic AMP-dependent transcriptional up-regulation of phospho-
diesterase 4D5 in human airway smooth muscle cells. Identifica-
tion and characterization of a novel PDE4D5 promoter. J Biol Chem
2002; 277: 35980–35989.
61 Fleischhacker WW, Hinterhuber H, Bauer H, Pflug B, Berner P,
Simhandl C et al. A multicenter double-blind study of three
different doses of the new cAMP-phosphodiesterase inhibitor
rolipram in patients with major depressive disorder. Neuropsy-
chobiology 1992; 26: 59–64.
62 Scott AI, Perini AF, Shering PA, Whalley LJ. In-patient major
depression: is rolipram as effective as amitriptyline? Eur J Clin
Pharmacol 1991; 40: 127–129.
63 Zhang HT, Huang Y, Jin SL, Frith SA, Suvarna N, Conti M et al.
Antidepressant-like profile and reduced sensitivity to rolipram in
mice deficient in the PDE4D phosphodiesterase enzyme. Neuro-
psychopharmacology 2002; 27: 587–595.
64 Wong ML, Whelan F, Deloukas P, Whittaker P, Delgado M,
Cantor RM et al. Phosphodiesterase genes are associated with
susceptibility to major depression and antidepressant treatment
response. Proc Natl Acad Sci USA 2006; 103: 15124–15129.
Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)
Whole genome association of neuroticism
S Shifman et al
312
Molecular Psychiatry
